in vivo Posted September 13, 2013 Report Share Posted September 13, 2013 Abstract The interaction between the endocannabinoid system and catecholaminergic circuits has gained increasing attention as it is recognized that the development of synthetic cannabinoid receptor agonists/antagonists or compounds targeting endocannabinoid synthesis/metabolism may hold some therapeutic potential for the treatment of psychiatric disorders. The noradrenergic system plays a critical role in the modulation of emotional state, primarily related to anxiety, arousal, and stress. Recent evidence suggests that the endocannabinoid system mediates stress responses and emotional homeostasis, in part, by targeting noradrenergic circuits. This review summarizes our current knowledge regarding the anatomical substrates underlying regulation of noradrenergic circuitry by the endocannabinoid system. It then presents biochemical evidence showing an important effect of cannabinoid modulation on adrenergic receptor signaling. Finally, new evidence from behavioral pharmacology studies is provided demonstrating that norepinephrine is a critical determinant of cannabinoid-induced aversion, adding another dimension to how central noradrenergic circuitry is regulated by the cannabinoid system. Copyright © 2012 Elsevier Inc. All rights reserved. http://www.ncbi.nlm.nih.gov/pubmed/22296986 Quote Link to comment Share on other sites More sharing options...
mrd Posted September 13, 2013 Report Share Posted September 13, 2013 Thanks for posting. http://www.ncbi.nlm.nih.gov/pubmed/22296986 Quote Link to comment Share on other sites More sharing options...
in vivo Posted September 13, 2013 Author Report Share Posted September 13, 2013 No problem at all. If you'd like I can post some related articles. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.